Therefore, our objectives were to investigate the possible relationship of apoB/apoA1 ratio and CHD in overweight and obese subjects, and to find whether apoB/apoA1 is better than LDL-C for prediction of cardiac risk, and to identify additional insights into the underlying atherothrombotic disease process in these patients. This evidence concerns the gene APOA1 and coronary artery disorder.